BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34028782)

  • 21. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
    Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ
    Front Immunol; 2020; 11():1933. PubMed ID: 33072067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prognostic risk model based on DNA methylation levels of genes and lncRNAs in lung squamous cell carcinoma.
    Wang W; Xiang M; Liu H; Chu X; Sun Z; Feng L
    PeerJ; 2022; 10():e13057. PubMed ID: 35356464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
    Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
    DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a glycolysis-related gene signature associated with clinical outcome for patients with lung squamous cell carcinoma.
    Xu Z; Zhang S; Nian F; Xu S
    Cancer Med; 2021 Jun; 10(12):4017-4029. PubMed ID: 33991070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients.
    Der SD; Sykes J; Pintilie M; Zhu CQ; Strumpf D; Liu N; Jurisica I; Shepherd FA; Tsao MS
    J Thorac Oncol; 2014 Jan; 9(1):59-64. PubMed ID: 24305008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis.
    Gao M; Kong W; Huang Z; Xie Z
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.
    Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C
    Front Immunol; 2023; 14():1236444. PubMed ID: 37841237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.
    Chen DT; Hsu YL; Fulp WJ; Coppola D; Haura EB; Yeatman TJ; Cress WD
    J Natl Cancer Inst; 2011 Dec; 103(24):1859-70. PubMed ID: 22157961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients.
    Liu X; Zhao D; Shan Y; Cui W; Xie Q; Jiang J; Peng W; Zhang C; Duan C
    Sci Rep; 2022 Dec; 12(1):20737. PubMed ID: 36456645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
    Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M
    Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma.
    Fang X; Liu X; Weng C; Wu Y; Li B; Mao H; Guan M; Lu L; Liu G
    Int J Med Sci; 2020; 17(17):2718-2727. PubMed ID: 33162799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.
    Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S
    Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival-associated N
    Qu J; Wang L; Jiang M; Wei Z; Fu G; Zhang X
    BMC Cancer; 2021 Nov; 21(1):1265. PubMed ID: 34814861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.
    Lu C; Bera K; Wang X; Prasanna P; Xu J; Janowczyk A; Beig N; Yang M; Fu P; Lewis J; Choi H; Schmid RA; Berezowska S; Schalper K; Rimm D; Velcheti V; Madabhushi A
    Lancet Digit Health; 2020 Nov; 2(11):e594-e606. PubMed ID: 33163952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
    Ke D; Guo Q; Fan TY; Xiao X
    Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
    [No Abstract]   [Full Text] [Related]  

  • 39. Comprehensive analyses of a CD8
    Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q
    BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma.
    Wan YW; Beer DG; Guo NL
    Lung Cancer; 2012 Apr; 76(1):98-105. PubMed ID: 22047960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.